Profile data is unavailable for this security.
About the company
SynAct Pharma AB is a manufacturer of biological products. The Company is located in Lund, Sweden. It develops medicines for acute impairment in inflammatory diseases. The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.
- Revenue in SEK (TTM)0.00
- Net income in SEK-190.84m
- Incorporated2016
- Employees5.00
- LocationSynAct Pharma ABScheelevagen 2LUND 22363SwedenSWE
- Websitehttps://synactpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aqua Bio Technology ASA | 13.31m | -1.48m | 229.08m | 2.00 | -- | 10.81 | 268.67 | 17.21 | -0.1599 | -0.1599 | 0.4938 | 0.3673 | 0.3079 | 0.6548 | 9.01 | -- | -3.42 | -80.72 | -6.75 | -125.29 | 66.69 | 5.57 | -11.12 | -965.98 | 0.1044 | 0.611 | 0.7538 | -- | 349.88 | 42.04 | 1.97 | -- | -- | -- |
| Opticept Technologies AB | 9.15m | -80.36m | 230.02m | 29.00 | -- | 0.5045 | -- | 25.15 | -2.62 | -2.62 | 0.2981 | 10.80 | 0.0213 | -0.0638 | 2.37 | 315,344.80 | -18.69 | -41.76 | -21.19 | -46.21 | 125.88 | 62.65 | -879.63 | -882.41 | 0.6163 | -14.16 | 0.0566 | -- | -12.90 | 49.17 | 19.80 | -- | 45.22 | -- |
| Corline Biomedical AB | 21.37m | -4.50m | 236.40m | 13.00 | -- | 2.58 | -- | 11.06 | -0.2092 | -0.2092 | 0.9944 | 4.26 | 0.2089 | -- | 6.96 | 1,643,846.00 | -4.39 | -5.71 | -4.80 | -6.24 | 115.99 | 128.60 | -21.04 | -38.46 | -- | -235.63 | 0.00 | -- | 6.28 | 74.14 | -177.67 | -- | 62.51 | -- |
| Thor Medical ASA | 0.00 | -5.48m | 239.21m | 1.00 | -- | 0.888 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Abliva AB | 137.00k | -97.60m | 243.43m | 6.00 | -- | 3.60 | -- | 1,776.85 | -0.0924 | -0.0924 | 0.0001 | 0.05 | 0.0013 | -- | 0.0045 | -- | -88.80 | -74.59 | -96.20 | -86.98 | -24,869.34 | -- | -71,240.15 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| Arctic Bioscience AS | 33.24m | -44.83m | 247.40m | 20.00 | -- | 0.9714 | -- | 7.44 | -1.79 | -1.79 | 1.33 | 10.19 | 0.1075 | 0.7025 | 2.93 | 1,687,501.00 | -14.50 | -- | -16.61 | -- | 28.96 | -- | -134.86 | -- | 2.53 | -- | 0.0079 | -- | -1.52 | -- | -33.77 | -- | -- | -- |
| Ultimovacs ASA | 0.00 | -175.22m | 253.84m | 25.00 | -- | 0.9942 | -- | -- | -5.17 | -5.17 | 0.00 | 7.53 | 0.00 | -- | -- | 0.00 | -44.31 | -28.80 | -50.09 | -31.12 | -- | -- | -- | -- | -- | -- | 0.0136 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
| Exact Therapeutics AS | 0.00 | -47.61m | 259.12m | 8.00 | -- | 5.83 | -- | -- | -1.51 | -1.51 | 0.00 | 1.41 | 0.00 | -- | -- | -- | -67.21 | -40.21 | -86.14 | -45.67 | -- | -- | -- | -- | -- | -16,578.57 | 0.0258 | -- | -- | -- | -20.52 | -- | -- | -- |
| Scandion Oncology A/S | 0.00 | -57.03m | 264.85m | 4.00 | -- | 2.36 | -- | -- | -0.4289 | -0.4289 | 0.00 | 0.2669 | 0.00 | -- | -- | 0.00 | -74.59 | -- | -87.90 | -- | -- | -- | -- | -- | -- | -- | 0.0113 | -- | -- | -- | 48.89 | -- | -- | -- |
| Saniona AB | 16.84m | -95.81m | 275.31m | 23.00 | -- | -- | -- | 16.35 | -1.29 | -1.29 | 0.2263 | -0.2895 | 0.1546 | -- | 4.71 | 732,173.90 | -87.96 | -59.16 | -108.11 | -70.15 | -213.08 | -970.05 | -568.94 | -1,483.55 | -- | -3.18 | 1.44 | -- | 10.19 | -21.05 | 54.71 | -- | -34.94 | -- |
| Intervacc AB | 8.93m | -102.77m | 277.19m | 15.00 | -- | 1.26 | -- | 31.05 | -1.40 | -1.40 | 0.1221 | 2.91 | 0.0365 | 3.25 | 1.55 | 595,066.70 | -41.96 | -17.62 | -45.32 | -18.77 | -589.11 | -243.59 | -1,151.30 | -626.90 | 4.33 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
| SynAct Pharma AB | 0.00 | -190.84m | 291.55m | 5.00 | -- | 1.65 | -- | -- | -5.65 | -5.65 | 0.00 | 4.28 | 0.00 | -- | -- | 0.00 | -71.43 | -125.17 | -79.52 | -151.70 | -- | -- | -- | -- | -- | -853.13 | 0.0033 | -- | -- | -- | -117.54 | -- | -- | -- |
| InDex Pharmaceuticals Holding AB | 108.34m | -56.48m | 297.24m | 7.00 | -- | 1.26 | -- | 2.74 | -0.1037 | -0.1037 | 0.2028 | 0.443 | 0.3559 | -- | -- | 15,477,000.00 | -18.55 | -37.64 | -21.24 | -41.14 | -46.98 | -450.51 | -52.13 | -454.62 | -- | -- | 0.0086 | -- | -- | 277.02 | 5.05 | -- | -- | -- |
| Lytix Biopharma AS | 3.93m | -86.58m | 337.19m | 10.00 | -- | 5.47 | -- | 85.77 | -2.16 | -2.16 | 0.0981 | 1.26 | 0.0368 | -- | 0.4091 | 399,100.00 | -80.96 | -56.91 | -94.07 | -65.83 | -- | -- | -2,202.36 | -771.78 | -- | -- | 0.0095 | -- | -63.82 | 63.94 | -56.77 | -- | -- | -- |
| Herantis Pharma Oyj | 0.00 | 3.19m | 352.38m | 10.00 | 122.12 | 6.55 | 110.59 | -- | 0.0126 | 0.0126 | 0.00 | 0.2344 | 0.00 | -- | -- | 0.00 | 4.31 | -80.46 | 6.16 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | 103.00 | -- | -- | -- |
| Medivir AB | 7.73m | -96.52m | 357.45m | 10.00 | -- | 1.69 | -- | 46.22 | -1.46 | -1.46 | 0.1028 | 1.89 | 0.032 | -- | 1.56 | 773,300.00 | -40.00 | -28.91 | -47.20 | -34.77 | -888.81 | -467.42 | -1,248.18 | -675.96 | -- | -- | 0.0482 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
Data as of Jun 07 2024. Currency figures normalised to SynAct Pharma AB's reporting currency: Swedish Krona SEK
13.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Heights Capital Management, Inc.as of 11 Oct 2023 | 3.75m | 10.54% |
| Handelsbanken Fonder ABas of 20 Jun 2023 | 441.08k | 1.24% |
| SEB Investment Management ABas of 30 Apr 2024 | 311.95k | 0.88% |
| FCG Fonder ABas of 31 Dec 2023 | 88.54k | 0.25% |
| Skandia Investment Management ABas of 28 Mar 2024 | 36.97k | 0.10% |
| Storebrand Asset Management ASas of 31 Jan 2024 | 12.47k | 0.04% |
| Danske Bank A/S (Investment Management)as of 31 May 2024 | 3.33k | 0.01% |
| Case Kapitalf�rvaltning ABas of 30 Nov 2022 | 2.84k | 0.01% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 523.00 | 0.00% |
| Andbank Wealth Management SGIIC SAUas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2022 - 31 May 2024Source: FactSet Research Systems Inc.
